Condition
Metabolic Dysfunction Associated Fatty Liver Disease
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07285135Not ApplicableNot Yet RecruitingPrimary
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT06939569Recruiting
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06773221Not ApplicableNot Yet RecruitingPrimary
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
NCT06749704Not ApplicableNot Yet RecruitingPrimary
Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD
Showing all 4 trials